Many somatic genetic alterations, including those in BRAF, HRAS, KRAS, NRAS, PTEN, and HER1, have had fundamental roles in the tumorigenesis of thyroid carcinoma. This evidence concerns the gene NRAS and thyroid gland carcinoma.